HGF

HGF

HGF 詳細

Molecule Name
Hepatocyte growth factor
分子の別称
HGF,HPTA,SF
Drug Development Progress
治験薬の数7
市販薬剤の数1
研究&開発段階Approved
ターゲットの別称
EC 3.4.21.7,Hepatocyte Growth Factor (Hepapoietin A; Scatter Factor),EC 3.4.21,HGF,Hepatopoietin-A,Scatter factor,Hepatocyte Growth Factor (Hepapoietin A,Scatter Factor),Fibroblast-Derived Tumor Cytotoxic Factor,Lung Fibroblast-Derived Mitogen,SF,Deafness, Autosomal Recessive 39,Hepatopoietin A,DFNB39,F-TCF,HGFB,Hepatocyte Growth Factor,HPTA
バックグランド
Hepatocyte growth factor (HGF) is a paracrine cellular growth, motility and morphogenic factor. Activating ligand for the receptor tyrosine kinase MET by binding to it and promoting its dimerization. Hepatocyte growth factor is secreted by mesenchymal cells and acts as a multi-functional cytokine on cells of mainly epithelial origin. Its ability to stimulate mitogenesis, cell motility, and matrix invasion gives it a central role in angiogenesis, tumorogenesis, and tissue regeneration. In addition, HGF has been implicated in a variety of cancers, including of the lungs, pancreas, thyroid, colon, and breast.

HGF 製品リスト

No Data
You Have Viewed 0 Of 0 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

治験薬に関する情報

英語名研究コード研究開発ステージ会社適応症臨床試験
FosgonimetonNDX-1017; ATH-1017; ATH 1017Phase 3 ClinicalM3 Biotechnology
Alzheimer Disease; Dementia; Lewy Body Disease; Parkinson Disease
詳細
RGL-2102RGL-2102; RGL2102Phase 3 ClinicalShanghai Regenelead Therapies Co Ltd
Diabetic Foot; Ischemia; Ulcer; Wound Infection
詳細
FiclatuzumabAV-299; SCH-900105Phase 3 ClinicalAveo
Carcinoma, Basal Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cholangiocarcinoma; Colonic Neoplasms; Glioblastoma; Head and Neck Neoplasms; Leukemia, Myeloid, Acute; Liver Neoplasms; Lung Neoplasms; Lymphoma; Multiple Myeloma; Oropharyngeal Neoplasms; Pancreatic Neoplasms; Respiratory Tract Neoplasms; Solid tumours; Squamous Cell Carcinoma of Head and Neck
詳細
UmikibartYYB-101; NOV-1105; CLM-101Phase 2 ClinicalYooYoung Pharmaceutical Co Ltd
Colorectal Neoplasms; Solid tumours
詳細
ATH-1020ATH-1020Phase 1 ClinicalAthira Pharma Inc
Nerve Degeneration
詳細
ATH-1105ATH-1105Phase 1 ClinicalAthira Pharma Inc
Amyotrophic Lateral Sclerosis; Frontotemporal Dementia
詳細
Microbiome-optimized autologous stem cell therapy (Biotech Holdings)ClinicalBiotech Holdings
Peripheral Vascular Diseases
詳細

市販薬剤に関する情報

英語名研究コード研究開発ステージ会社オリジナル製品名最初に承認をした国最初の適応症最初に承認を受けた会社承認された日付適応症臨床試験
Beperminogene perplasmidAMG-0001-01; AMG-0001; DS-992; TREAT-HGFApprovedAnges Mg, Osaka UniversityCollategeneJapanPeripheral Arterial Disease; IschemiaAnges Inc, null2019-03-01
Arterial Occlusive Diseases; Atherosclerosis; Foot Ulcer; Ischemia; Peripheral Arterial Disease; Peripheral Vascular Diseases; Ulcer; Vascular Diseases
詳細